Synthesis and biological evaluation of a beauveriolide analogue library

J Comb Chem. 2006 Jan-Feb;8(1):103-9. doi: 10.1021/cc050084d.

Abstract

Synthesis of beauveriolide III (1b), which is an inhibitor of lipid droplet accumulation in macrophages, was achieved by solid-phase assembly of linear depsipeptide using a 2-chlorotrityl linker followed by solution-phase cyclization. On the basis of this strategy, a combinatorial library of beauveriolide analogues was carried out by radio frequency-encoded combinatorial chemistry. After automated purification using preparative reversed-phase HPLC, the library was tested for inhibitory activity of CE synthesis in macrophages to determine structure-activity relationships of beauveriolides. Among them, we found that diphenyl derivative 7{9,1} is 10 times more potent than 1b.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cholesterol Esters / antagonists & inhibitors
  • Cholesterol Esters / biosynthesis
  • Chromatography, High Pressure Liquid
  • Combinatorial Chemistry Techniques / methods*
  • Cyclization
  • Depsipeptides / chemical synthesis*
  • Depsipeptides / chemistry
  • Depsipeptides / pharmacology
  • Hypolipidemic Agents / chemical synthesis*
  • Hypolipidemic Agents / chemistry
  • Hypolipidemic Agents / pharmacology
  • Macrophages, Peritoneal / drug effects
  • Macrophages, Peritoneal / metabolism
  • Mice
  • Molecular Structure
  • Structure-Activity Relationship

Substances

  • Cholesterol Esters
  • Depsipeptides
  • Hypolipidemic Agents
  • beauverolides